Solutions beyond the surface


TOPICA Pharmaceuticals, Inc. was focused on developing luliconazole for the treatment of onychomycosis, or fungal infections of the nail. The company wound down operations in 2016.


Year Invested: 2011
Location: Los Altos, Calif.

Associated Team Members

Charles Homcy, M.D.
Partner

Neil Exter
Partner